{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T01:00:24Z","timestamp":1774486824996,"version":"3.50.1"},"reference-count":84,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.hfc.2025.11.003","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T12:31:06Z","timestamp":1766406666000},"page":"149-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Approach to Ventricular Arrhythmias in Heart Failure"],"prefix":"10.1016","volume":"22","author":[{"given":"Andrea N.","family":"Keithler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klitos","family":"Konstantinidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6Part B","key":"10.1016\/j.hfc.2025.11.003_bib1","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.hroo.2021.08.007","article-title":"Management of ventricular arrhythmias in heart failure: current perspectives","volume":"2","author":"Peichl","year":"2021","journal-title":"Heart Rhythm O2"},{"issue":"12","key":"10.1016\/j.hfc.2025.11.003_bib2","doi-asserted-by":"crossref","first-page":"H2451","DOI":"10.1152\/ajpheart.00770.2011","article-title":"Mechanisms of ventricular arrhythmias: a dynamical systems-based perspective","volume":"302","author":"Cherry","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"10.1016\/j.hfc.2025.11.003_bib3","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00001573-200005000-00014","article-title":"Molecular aspects of arrhythmias associated with cardiomyopathies","volume":"15","author":"Tomaselli","year":"2000","journal-title":"Curr Opin Cardiol"},{"issue":"13","key":"10.1016\/j.hfc.2025.11.003_bib4","first-page":"e272","volume":"138","author":"Al-Khatib","year":"2018","journal-title":"Circulation"},{"issue":"40","key":"10.1016\/j.hfc.2025.11.003_bib5","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.hfc.2025.11.003_bib6","doi-asserted-by":"crossref","first-page":"e281","DOI":"10.1097\/CCM.0000000000002089","article-title":"Effectiveness of extracorporeal life support for patients with cardiogenic shock due to intractable arrhythmic storm","volume":"45","author":"Le Pennec-Prigent","year":"2017","journal-title":"Crit Care Med"},{"issue":"10","key":"10.1016\/j.hfc.2025.11.003_bib7","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMoa071098","article-title":"Prognostic importance of defibrillator shocks in patients with heart failure","volume":"359","author":"Poole","year":"2008","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.hfc.2025.11.003_bib8","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1056\/NEJMoa1211107","article-title":"Reduction in inappropriate therapy and mortality through ICD programming","volume":"367","author":"Moss","year":"2012","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.hfc.2025.11.003_bib9","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1161\/CIRCULATIONAHA.120.047468","article-title":"Effectiveness of deep sedation for patients with intractable electrical storm refractory to antiarrhythmic drugs","volume":"142","author":"Martins","year":"2020","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.hfc.2025.11.003_bib10","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1111\/jce.13324","article-title":"Stellate ganglion blockade for the treatment of refractory ventricular arrhythmias: a systematic review and meta-analysis","volume":"28","author":"Fudim","year":"2017","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"9","key":"10.1016\/j.hfc.2025.11.003_bib11","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.jacep.2017.06.006","article-title":"Efficacy of stellate ganglion blockade in managing electrical storm: a systematic review","volume":"3","author":"Meng","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"issue":"3","key":"10.1016\/j.hfc.2025.11.003_bib12","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.hrthm.2013.11.028","article-title":"Cardiac sympathetic denervation in patients with refractory ventricular arrhythmias or electrical storm: intermediate and long-term follow-up","volume":"11","author":"Vaseghi","year":"2014","journal-title":"Heart Rhythm"},{"issue":"25","key":"10.1016\/j.hfc.2025.11.003_bib13","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1016\/j.jacc.2017.04.035","article-title":"Cardiac sympathetic denervation for refractory ventricular arrhythmias","volume":"69","author":"Vaseghi","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2025.11.003_bib14","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.hrthm.2017.08.022","article-title":"Successful VT ablation in patients with electrical storm reduces recurrences and improves survival","volume":"15","author":"Vergara","year":"2018","journal-title":"Heart Rhythm"},{"issue":"4","key":"10.1016\/j.hfc.2025.11.003_bib15","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1161\/CIRCULATIONAHA.106.686534","article-title":"Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single-center study","volume":"117","author":"Carbucicchio","year":"2008","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.hfc.2025.11.003_bib16","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jacep.2017.01.020","article-title":"Long-term outcomes of catheter ablation of electrical storm in nonischemic dilated cardiomyopathy compared with ischemic cardiomyopathy","volume":"3","author":"Muser","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"issue":"7","key":"10.1016\/j.hfc.2025.11.003_bib17","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.amjcard.2015.01.020","article-title":"Effect of angiotensin-converting enzyme inhibitors and receptor blockers on appropriate implantable cardiac defibrillator shock in patients with severe systolic heart failure (from the GRADE Multicenter Study)","volume":"115","author":"AlJaroudi","year":"2015","journal-title":"Am J Cardiol"},{"issue":"14","key":"10.1016\/j.hfc.2025.11.003_bib18","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.hfc.2025.11.003_bib19","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.hfc.2025.11.003_bib20","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with Empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.hfc.2025.11.003_bib21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0735-1097(97)00104-6","article-title":"Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials","volume":"30","author":"Heidenreich","year":"1997","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.hfc.2025.11.003_bib22","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1161\/CIR.0000000000000426","article-title":"Drugs that may cause or exacerbate heart failure: a scientific statement from the American Heart Association","volume":"134","author":"Page","year":"2016","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.hfc.2025.11.003_bib23","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199103213241201","article-title":"Mortality and morbidity in patients receiving encainide, flecainide, or placebo. the cardiac arrhythmia suppression trial","volume":"324","author":"Echt","year":"1991","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.hfc.2025.11.003_bib24","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.jacep.2024.01.021","article-title":"Class 1C antiarrhythmics for premature ventricular complex suppression in nonischemic cardiomyopathy with implantable cardioverter-defibrillators","volume":"10","author":"Raad","year":"2024","journal-title":"JACC Clin Electrophysiol"},{"issue":"4","key":"10.1016\/j.hfc.2025.11.003_bib25","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1161\/01.CIR.82.4.1106","article-title":"Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. a meta-analysis of randomized control trials","volume":"82","author":"Coplen","year":"1990","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.hfc.2025.11.003_bib26","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/0002-9149(90)90972-4","article-title":"Effect of empiric antiarrhythmic therapy in resuscitated out-of-hospital cardiac arrest victims with coronary artery disease","volume":"65","author":"Moosvi","year":"1990","journal-title":"Am J Cardiol"},{"issue":"25","key":"10.1016\/j.hfc.2025.11.003_bib27","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1056\/NEJMoa0800456","article-title":"Increased mortality after dronedarone therapy for severe heart failure","volume":"358","author":"K\u00f8ber","year":"2008","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.hfc.2025.11.003_bib28","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0002-9149(99)80717-6","article-title":"Survival with oral d-sotalol in patients with left ventricular dysfunction after myocardial infarction: rationale, design, and methods (the SWORD trial)","volume":"75","author":"Waldo","year":"1995","journal-title":"Am J Cardiol"},{"issue":"24","key":"10.1016\/j.hfc.2025.11.003_bib29","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1053\/euhj.2000.2476","article-title":"Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. antiarrhythmics vs implantable defibrillator study. cardiac arrest study Hamburg . Canadian implantable defibrillator study","volume":"21","author":"Connolly","year":"2000","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.hfc.2025.11.003_bib30","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced EF","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.hfc.2025.11.003_bib31","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.hfc.2025.11.003_bib32","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa033088","article-title":"Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy","volume":"350","author":"Kadish","year":"2004","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.hfc.2025.11.003_bib33","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1093\/europace\/euq329","article-title":"Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with ischaemic or non-ischaemic heart disease: a systematic review and meta-analysis","volume":"12","author":"Theuns","year":"2010","journal-title":"Europace"},{"issue":"19","key":"10.1016\/j.hfc.2025.11.003_bib34","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1161\/CIRCULATIONAHA.119.043012","article-title":"Association between use of primary-prevention implantable cardioverter-defibrillators and mortality in patients with heart failure: a prospective propensity score-matched analysis from the swedish heart failure registry","volume":"140","author":"Schrage","year":"2019","journal-title":"Circulation"},{"issue":"36","key":"10.1016\/j.hfc.2025.11.003_bib35","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1093\/eurheartj\/ehaa226","article-title":"Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study","volume":"41","author":"Zabel","year":"2020","journal-title":"Eur Heart J"},{"issue":"13","key":"10.1016\/j.hfc.2025.11.003_bib36","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"K\u00f8ber","year":"2016","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.hfc.2025.11.003_bib37","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/heartjnl-2016-310850","article-title":"Non-ischaemic cardiomyopathy, sudden death and implantable defibrillators: a review and meta-analysis","volume":"104","author":"Beggs","year":"2018","journal-title":"Heart"},{"issue":"6","key":"10.1016\/j.hfc.2025.11.003_bib38","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1056\/NEJMoa1915932","article-title":"Subcutaneous or transvenous defibrillator therapy","volume":"383","author":"Knops","year":"2020","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.hfc.2025.11.003_bib39","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/CIRCULATIONAHA.124.071795","article-title":"Performance and safety of the extravascular implantable cardioverter defibrillator through long-term follow-up: final results from the pivotal study","volume":"151","author":"Friedman","year":"2025","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.hfc.2025.11.003_bib40","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.jacc.2008.08.027","article-title":"Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms","volume":"52","author":"Linde","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.hfc.2025.11.003_bib41","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2005.09.016","article-title":"Mode of death in advanced heart failure: the comparison of medical, pacing, and defibrillation therapies in heart failure (COMPANION) trial","volume":"46","author":"Carson","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.hfc.2025.11.003_bib42","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/ejhf.152","article-title":"Super-responders to cardiac resynchronization therapy remain at risk for ventricular arrhythmias and benefit from defibrillator treatment","volume":"16","author":"van der Heijden","year":"2014","journal-title":"Eur J Heart Fail"},{"issue":"14","key":"10.1016\/j.hfc.2025.11.003_bib43","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJMoa0906431","article-title":"Cardiac-resynchronization therapy for the prevention of heart-failure events","volume":"361","author":"Moss","year":"2009","journal-title":"N Engl J Med"},{"issue":"27","key":"10.1016\/j.hfc.2025.11.003_bib44","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/eurheartj\/ehac053","article-title":"Survival of patients undergoing cardiac resynchronization therapy with or without defibrillator: the RESET-CRT project","volume":"43","author":"Hadwiger","year":"2022","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.hfc.2025.11.003_bib45","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/CIRCEP.114.002394","article-title":"Characteristics of VT ablation in patients with continuous flow left ventricular assist devices","volume":"8","author":"Sacher","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"12","key":"10.1016\/j.hfc.2025.11.003_bib46","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.hrthm.2017.07.027","article-title":"Predictors of ventricular arrhythmia after left ventricular assist device implantation: a large single-center observational study","volume":"14","author":"Efimova","year":"2017","journal-title":"Heart Rhythm"},{"issue":"17","key":"10.1016\/j.hfc.2025.11.003_bib47","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1161\/CIR.0b013e31825d59fd","article-title":"Educational and psychological interventions to improve outcomes for recipients of implantable cardioverter defibrillators and their families: a scientific statement from the American Heart Association","volume":"126","author":"Dunbar","year":"2012","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.hfc.2025.11.003_bib48","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1161\/01.CIR.0000150390.04704.B7","article-title":"Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator","volume":"110","author":"Moss","year":"2004","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.hfc.2025.11.003_bib49","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1513614","article-title":"VT ablation versus Escalation of antiarrhythmic drugs","volume":"375","author":"Sapp","year":"2016","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.hfc.2025.11.003_bib50","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.295.2.165","article-title":"Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial","volume":"295","author":"Connolly","year":"2006","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.hfc.2025.11.003_bib51","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/eurheartj\/ehp100","article-title":"Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials","volume":"30","author":"Piccini","year":"2009","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.hfc.2025.11.003_bib52","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/europace\/euz132","article-title":"2019 HRS\/EHRA\/APHRS\/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias","volume":"21","author":"Cronin","year":"2019","journal-title":"Europace"},{"issue":"2","key":"10.1016\/j.hfc.2025.11.003_bib53","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/01.CIR.20.2.251","article-title":"Cardiac aneurysm with VT and subsequent excision of aneurysm; case report","volume":"20","author":"COUCH","year":"1959","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.hfc.2025.11.003_bib54","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0002-9149(82)90297-1","article-title":"Relative efficacy of blind left ventricular aneurysm resection for the treatment of recurrent VT","volume":"49","author":"Mason","year":"1982","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.hfc.2025.11.003_bib55","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0003-4975(10)62923-2","article-title":"Encircling endocardial ventriculotomy: a new surgical treatment for life-threatening VTs resistant to medical treatment following myocardial infarction","volume":"26","author":"Guiraudon","year":"1978","journal-title":"Ann Thorac Surg"},{"issue":"7","key":"10.1016\/j.hfc.2025.11.003_bib56","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1161\/01.CIR.60.7.1430","article-title":"Endocardial excision: a new surgical technique for the treatment of recurrent VT","volume":"60","author":"Josephson","year":"1979","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.hfc.2025.11.003_bib57","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0735-1097(83)80337-4","article-title":"Electrode catheter ablation of refractory focal VT","volume":"2","author":"Hartzler","year":"1983","journal-title":"J Am Coll Cardiol"},{"issue":"4 Pt 1","key":"10.1016\/j.hfc.2025.11.003_bib58","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1161\/01.CIR.88.4.1647","article-title":"Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of VT late after myocardial infarction","volume":"88","author":"Stevenson","year":"1993","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.hfc.2025.11.003_bib59","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1161\/01.CIR.88.3.915","article-title":"Slow conduction in the infarcted human heart. 'Zigzag' course of activation","volume":"88","author":"de Bakker","year":"1993","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.hfc.2025.11.003_bib60","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/01.CIR.0000083725.72693.EA","article-title":"Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic VT","volume":"108","author":"Hsia","year":"2003","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.hfc.2025.11.003_bib61","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11886-016-0742-9","article-title":"Outcomes of catheter ablation of VT in the setting of structural heart disease","volume":"18","author":"Betensky","year":"2016","journal-title":"Curr Cardiol Rep"},{"issue":"23","key":"10.1016\/j.hfc.2025.11.003_bib62","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1016\/j.jacc.2017.10.030","article-title":"Catheter ablation of VT in structural heart disease: indications, strategies, and outcomes-part II","volume":"70","author":"Dukkipati","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.hfc.2025.11.003_bib63","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jacep.2018.06.014","article-title":"VT ablation in nonischemic cardiomyopathy","volume":"4","author":"Zeppenfeld","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"issue":"12","key":"10.1016\/j.hfc.2025.11.003_bib64","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.jacep.2019.09.015","article-title":"VT ablation: past, present, and Future perspectives","volume":"5","author":"Guandalini","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"issue":"9","key":"10.1016\/j.hfc.2025.11.003_bib65","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.hrthm.2015.05.036","article-title":"Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: an International VT Ablation Center Collaborative Group study","volume":"12","author":"Tung","year":"2015","journal-title":"Heart Rhythm"},{"issue":"7","key":"10.1016\/j.hfc.2025.11.003_bib66","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1161\/CIRCULATIONAHA.113.003063","article-title":"Outcomes in catheter ablation of VT in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy: results from the prospective heart centre of leipzig VT (HELP-VT) study","volume":"129","author":"Dinov","year":"2014","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.hfc.2025.11.003_bib67","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/europace\/euu326","article-title":"Substrate-guided ablation of haemodynamically tolerated and untolerated VT in patients with structural heart disease: effect of cardiomyopathy type and acute success on long-term outcome","volume":"17","author":"Proietti","year":"2015","journal-title":"Europace"},{"issue":"26","key":"10.1016\/j.hfc.2025.11.003_bib68","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1056\/NEJMoa065457","article-title":"Prophylactic catheter ablation for the prevention of defibrillator therapy","volume":"357","author":"Reddy","year":"2007","journal-title":"N Engl J Med"},{"issue":"9708","key":"10.1016\/j.hfc.2025.11.003_bib69","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(09)61755-4","article-title":"Catheter ablation of stable VT before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial","volume":"375","author":"Kuck","year":"2010","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.hfc.2025.11.003_bib70","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jacep.2018.01.013","article-title":"Targeting the hidden substrate unmasked by right ventricular extrastimulation improves VT ablation outcome after myocardial infarction","volume":"4","author":"de Riva","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"issue":"18","key":"10.1016\/j.hfc.2025.11.003_bib71","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1161\/CIRCULATIONAHA.111.043216","article-title":"Elimination of local abnormal ventricular activities: a new end point for substrate modification in patients with scar-related VT","volume":"125","author":"Ja\u00efs","year":"2012","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.hfc.2025.11.003_bib72","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1161\/CIRCULATIONAHA.122.060039","article-title":"First-line catheter ablation of monomorphic ventricular tachycardia in cardiomyopathy Concurrent with defibrillator implantation: the PAUSE-SCD randomized trial","volume":"145","author":"Tung","year":"2022","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.hfc.2025.11.003_bib73","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1161\/CIRCULATIONAHA.122.059598","article-title":"Does timing of ventricular tachycardia ablation affect prognosis in patients with an implantable cardioverter defibrillator? results from the multicenter randomized PARTITA trial","volume":"145","author":"Della Bella","year":"2022","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.hfc.2025.11.003_bib74","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s10840-023-01483-2","article-title":"Efficacy and safety of catheter ablation as first-line therapy for the management of ventricular tachycardia","volume":"66","author":"Kotake","year":"2023","journal-title":"J Intervent Card Electrophysiol"},{"issue":"8","key":"10.1016\/j.hfc.2025.11.003_bib75","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1056\/NEJMoa2409501","article-title":"Catheter ablation or antiarrhythmic drugs for ventricular tachycardia","volume":"392","author":"Sapp","year":"2025","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.hfc.2025.11.003_bib76","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1056\/NEJMoa1613773","article-title":"Noninvasive cardiac radiation for ablation of ventricular tachycardia","volume":"377","author":"Cuculich","year":"2017","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.hfc.2025.11.003_bib77","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.radonc.2018.04.025","article-title":"Rescue procedure for an electrical storm using robotic non-invasive cardiac radio-ablation","volume":"128","author":"Jumeau","year":"2018","journal-title":"Radiother Oncol"},{"issue":"7","key":"10.1016\/j.hfc.2025.11.003_bib78","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/europace\/euz133","article-title":"Stereotactic radiosurgery for ablation of ventricular tachycardia","volume":"21","author":"Neuwirth","year":"2019","journal-title":"Europace"},{"issue":"8","key":"10.1016\/j.hfc.2025.11.003_bib79","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.hrthm.2020.02.036","article-title":"Stereotactic arrhythmia radioablation for refractory scar-related ventricular tachycardia","volume":"17","author":"Gianni","year":"2020","journal-title":"Heart Rhythm"},{"issue":"3","key":"10.1016\/j.hfc.2025.11.003_bib80","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.hrthm.2019.09.028","article-title":"Clinical experience of stereotactic body radiation for refractory ventricular tachycardia in advanced heart failure patients","volume":"17","author":"Lloyd","year":"2020","journal-title":"Heart Rhythm"},{"issue":"1","key":"10.1016\/j.hfc.2025.11.003_bib81","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jacep.2021.06.016","article-title":"Substrate modification using stereotactic radioablation to treat refractory ventricular tachycardia in patients with ischemic cardiomyopathy","volume":"8","author":"Qian","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"issue":"2","key":"10.1016\/j.hfc.2025.11.003_bib82","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s10840-021-01060-5","article-title":"Stereotactic radioablation for the treatment of ventricular tachycardia: preliminary data and insights from the STRA-MI-VT phase Ib\/II study","volume":"62","author":"Carbucicchio","year":"2021","journal-title":"J Intervent Card Electrophysiol"},{"issue":"9","key":"10.1016\/j.hfc.2025.11.003_bib83","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.122.010955","article-title":"Stereotactic radioablation for VT in the setting of electrical storm","volume":"15","author":"Ninni","year":"2022","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"1","key":"10.1016\/j.hfc.2025.11.003_bib84","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10840-022-01352-4","article-title":"Stereotactic body radioablation therapy as an immediate and early term antiarrhythmic palliative therapeutic choice in patients with refractory ventricular tachycardia","volume":"66","author":"Aras","year":"2023","journal-title":"J Intervent Card Electrophysiol"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713625001059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713625001059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:25:26Z","timestamp":1774484726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713625001059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":84,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1551713625001059"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2025.11.003","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Approach to Ventricular Arrhythmias in Heart Failure","name":"articletitle","label":"Article Title"},{"value":"Heart Failure Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hfc.2025.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}